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Case Presentation
In June 2000 a 65-year-old man was hospital-
ized for recently developed ascites, indeﬁnite
abdominal pain, dyspepsia, and mild
hepatomegaly (echographic finding). He
reported occasional abuse of alcoholic bever-
ages and lifelong heavy smoking (40 ciga-
rettes/day). The patient had worked in the
building industry from 14 to 55 years of age
(1949–1990), when he retired. His duties
(installation of industrial rooﬁng, pipes, ﬂues,
and tanks) required cutting and shaping
asbestos-cement panels with an electric saw
and a rotating abrasive disk, exposing him to
the inhalation of asbestos fibers. Routine
blood and urine analyses (including indicators
of liver function) were normal. Viral hepatitis
(B and C) markers were negative. Chest radi-
ography and lung function tests revealed
chronic obstructive pulmonary disease
(COPD). Esophagogastroduodenoscopy dis-
closed mild gastroduodenitis. Abdominal
computed tomography (CT) excluded the
presence of expansive processes. Evacuative
paracentesis was performed: the ascitic fluid
was clear, and cytologic analysis did not detect
abnormal cells.
In the following months, ascites re-
formed quickly after repeated paracentesis.
Percutaneous liver biopsy (December 2000)
showed normal hepatic histology. Laparoscopy
(April 2001) revealed diffuse neoplastic inﬁl-
tration of the peritoneum and greater omen-
tum, with a carcinomatous aspect. Several
bioptic samples were collected; standard
histopathologic examination demonstrated
epithelioid neoplastic proliferation with a
tubulopapillary pattern (Figure 1), suggesting
metastatic peritoneal adenocarcinomatosis.
Further diagnostic procedures (colorectal radi-
ology and endoscopy, magnetic resonance
imaging of the abdomen, chest CT, and
pelvic, transrectal, and testicular ultrasonogra-
phy) failed to identify the hypothetical primi-
tive tumor. The occupational history of
long-term asbestos exposure prompted us to
conduct immunohistochemical tests on the
neoplastic tissue samples. Staining for the
carcinoembrionary antigen (CEA) and the
epithelial glycoprotein Ber-EP4 was negative,
whereas results for the mesothelial markers
cytokeratins, calretinin (Figure 2), epithelial
membrane antigen (EMA), and HBME-1
(Figure 3) were positive, leading to the diag-
nosis of peritoneal epithelial mesothelioma.
In May 2001 the patient underwent bilat-
eral subphrenic peritonectomy, partial pan-
creasectomy, splenectomy, appendicectomy,
and cytoreductive debulking of neoplastic
nodules larger than 3 mm. This was followed
by peritoneal perfusion with cisplatin heated
at 42°C for 1 hr. After overcoming severe
postoperative complications (delayed ady-
namic ileus, Candida tropicalis septicemia,
and Clostridium difﬁcile bowel infection), the
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Occupational and environmental asbestos exposure continues to represent a public health prob-
lem, despite increasingly restrictive laws adopted by most industrialized countries. Peritoneal
mesothelioma is a rare and aggressive asbestos-related malignancy. We present the case of a
65-year-old man who developed recurrent ascites after having been exposed to asbestos in the
building industry for > 40 years. Liver function and histology were normal. Abdominal computed
tomography initially excluded the presence of expansive processes, and no abnormal cells were
found in the ascitic ﬂuid. Laparoscopy showed diffuse neoplastic inﬁltration of the peritoneum.
Histopathology of bioptic samples revealed epithelioid neoplastic proliferation with a tubulopapil-
lary pattern, falsely suggesting metastatic adenocarcinomatosis. In consideration of the occupa-
tional history, and after further diagnostic procedures had failed to identify the hypothetical
primitive tumor, immunostaining of the neoplastic tissue was performed. Results were negative
for carcinoembrionary antigen and the epithelial glycoprotein Ber-EP4, whereas results were posi-
tive for the mesothelial markers cytokeratins, calretinin, epithelial membrane antigen, and
HBME-1, thus leading to the correct diagnosis of peritoneal epithelial mesothelioma. The Italian
Workers’ Compensation Authority recognized the occupational origin of the disease.
Cytoreductive surgery associated with continuous hyperthermic peritoneal perfusion (cisplatin at
42°C, for 1 hr) was performed. The disease relapsed after 4 months and was later complicated by
a bowel obstruction requiring palliative ileostomy. The patient died 23 months after diagnosis.
This case illustrates the insidious diagnostic problems posed by peritoneal mesothelioma, a tumor
which often simulates other malignancies (e.g., metastatic carcinomas) at routine histopathological
examination. Occupational history and immunohistochemistry are helpful for the correct diagno-
sis, which, in turn, is important in relation to prognosis and treatment (adoption of new inte-
grated procedures that seem to promise prolonged survival and increased quality of life), and in
relation to medicolegal issues and occupation-related compensation claims following asbestos
exposure. Key words: calretinin, cisplatin, HBME-1, intraperitoneal chemotherapy, occupational
cancer, peritonectomy. Environ Health Perspect 112:616–619 (2004). doi:10.1289/ehp.6542
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tions (July 2001). He remained apparently
free of disease for 4 months, after which
ascites reformed. Abdominal ultrasonography
indicated disease relapse.
In February 2003 the subject was readmit-
ted to the hospital with a clinical picture sug-
gestive of intestinal obstruction, which was
confirmed at colonoscopy. Surgery revealed
the presence of diffuse peritoneal neoplastic
infiltration involving the intestinal loops.
Palliative ileostomy was performed. The sub-
ject died 1 month later at 67 years of age.
Discussion
Malignant peritoneal mesothelioma was ﬁrst
described in 1908 by Miller and Wynn; it is a
rare, locally aggressive neoplasm arising from
the abdominal serosal lining, and exposure to
asbestos ﬁbers has been recognized as a princi-
pal etiopathogenetic agent (Antman 1993;
Vogelzang 2002). The disease is more com-
mon in men, possibly because of the higher
male occupational exposure to asbestos
(Antman 1993; Attanoos and Gibbs 1997).
Diagnosis of peritoneal mesothelioma
(particularly the differentiation from the more
common metastatic peritoneal cancers) is
often difﬁcult and delayed, both for the non-
specific clinical manifestations of the disease
(abdominal pain, ascites, abdominal masses)
and its extreme morphologic variability
(Attanoos and Gibbs 1997; Sugarbaker et al.
2002). In the reported patient, the clinical pic-
ture was dominated by recurrent ascites.
Normality of both liver function and histology
excluded the presence of hepatic disease.
Deﬁnition of the neoplastic nature of ascites
required exploratory laparoscopy. Routine his-
tologic examination of neoplastic tissue was
initially misleading, suggesting metastatic
invasion of the peritoneum by occult adeno-
carcinoma. Besides mesothelioma, a variety of
other abdominal and pelvic malignancies (e.g.,
gastrointestinal or genitourinary cancer) may
in fact present with peritoneal seeding. With
hematoxylin-eosin staining, epithelial (epithe-
lioid) mesothelioma (the most common
histopathological subtype, 50–75% of cases)
may present the same morphology of glandu-
lar carcinomas, as in this case. Sarcomatous (or
sarcomatoid) mesothelioma (15–20%) may in
turn simulate sarcomas originating from con-
nectival tissue (e.g., fibrosarcoma). The only
pathognomonic phenotype is the mixed (or
biphasic) mesothelioma (20–30%), where
epithelioid and sarcomatoid tissues coexist.
Histologic diagnosis of rare morphologic vari-
ants (e.g., small-cell, desmoplastic, or lympho-
histiocytoid mesothelioma) may also be
problematic (Attanoos and Gibbs 1997;
Sugarbaker et al. 2002).
In this patient, the negative results of
CEA and Ber-EP4 immunohistochemistry
allowed us to exclude reactivity of the bioptic
samples with epithelial-binding antibodies,
whereas results of immunohistochemistry for
cytokeratins, calretinin, EMA and HBME-1
indicated reactivity of the neoplastic tissue
with antibodies that preferentially bind cells
of mesothelial origin (Attanoos and Gibbs
1997; King and Hasleton 2001). As a discr-
minant marker, calretinin (a calcium-binding
protein) shows high sensitivity and speciﬁcity
for mesothelioma (Doglioni et al. 1996; Leers
et al. 1998), particularly for the epithelial sub-
type (Attanoos et al. 2001). Thus, immuno-
staining allowed us to formulate the correct
diagnosis of primary peritoneal mesothelioma
(epithelial subtype) excluding metastatic
adenocarcinomatosis.
Besides immunohistochemistry, one ele-
ment that significantly helped us formulate
the diagnosis was the patient’s occupational
history of prolonged asbestos exposure in the
building industry. Due to its physicochemical
characteristics (resistance to mechanical
agents, electricity, chemicals, heat, and fire
and textile, insulating, and hygroscopic prop-
erties) and relatively low cost, asbestos was
widely used until recently in a variety of
industrial processes. Other than construction
(asbestos-cement, fireproof panels), asbestos
has also been used in the automobile, railway,
naval, and aerospatial industries (insulating
and fireproof coatings, brake and clutch lin-
ings); metallurgy (shields, protective cloth-
ing); the textile industry (asbestos-made
blankets and overalls; linings of warping,
looming, and combing machines; Chiappino
et al. 2003); and food processing (asbestos ﬁl-
ters). In 1990, the estimated worldwide pro-
duction of asbestos (used in approximately
1,500 industrial processes) was 4,500,000
tons/year (Candura and Candura 2002).
Occupational and environmental asbestos
exposure may cause asbestosis (evolutive lung
ﬁbrosis), pleural ﬁbrosis and calciﬁcation, lung
cancer, and mesotheliomas, with a risk pro-
portional to the duration and intensity of
exposure (Antman 1993; Magnani et al. 1998;
Rom et al. 2001; Rubino et al. 1972; Selikoff
1978). The first reports on the carcinogenic
effect of asbestos on the lung date back to
1935 (Gloyne 1935; Lynch and Smith 1935),
whereas asbestos-related mesotheliomas, both
pleural (Wagner et al. 1960) and peritoneal
(Keal 1960), were ﬁrst described in 1960. The
mechanisms underlying asbestos-induced
oncogenesis are not completely understood.
Apparently, asbestos plays a cocarcinogen role
in lung cancer, with promoter-like activity and
synergism with smoking, whereas in mesothe-
lioma it acts as a complete carcinogen. Oxygen
free radicals appear to have a pivotal role in
the process, exerting direct and indirect geno-
toxic effects on the mesothelial cells (Attanoos
and Gibbs 1997; Walker et al. 1992).
The implication of asbestos in the causa-
tion of peritoneal mesothelioma is less evident
than in pleural mesothelioma (Peterson et al.
1984). The abdominal localization seems to
require a particularly intense and prolonged
exposure (Browne and Smither 1983;
Selikoff 1978). Several hypothesis have been
formulated to explain the mechanism by
which asbestos reaches the peritoneum. In
experimental animals, asbestos fibers pene-
trate the gastrointestinal wall after ingestion
(Masse et al. 1980), and asbestos bodies have
been found within some human peritoneal
mesotheliomas (Hourihane 1965). It has
therefore been postulated that ingestion of
ﬁbers, either directly from contaminated food
or indirectly from expectorated sputum, may
be one route for asbestos transmission to the
peritoneum (Craighead and Mossman 1982).
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Figure 2. Bioptical peritoneal sample showing
positive diffused immunoreactivity for calretinin
(magnification, 200×).
Figure 3. Bioptical peritoneal sample showing
immunohistochemical reaction for HBME-1, indicated
by intense and diffuse positivity of cytoplasmatic
membranes (magniﬁcation, 200×).
Figure 1. Bioptical peritoneal sample showing neo-
plastic proliferation with papillary and glandular
features and stromal inﬁltration (hematoxylin-eosin;
magniﬁcation, 100×).Other possible mechanisms are permeation of
diaphragmatic stomata and hematic/lymphatic
transport (Auerbach et al. 1980).
Beginning in the 1970s, both the United
States and the European community progres-
sively introduced restrictive laws concerning
the sale and use of asbestos. Italy deﬁnitively
banned its extraction, import/export, and use
in 1992. Nevertheless, asbestos continues to
represent a public health concern for at least
three reasons (Chiappino 1998). First, people
exposed in the past (especially in the work
environment) are still at risk because asbestos-
induced desease, especially cancer, may develop
up to 40 years after exposure (Lanphear and
Buncher 1992; Vogelzang 2002). Projections
based on epidemiologic data suggest that the
number of men dying from pleural mesothe-
lioma in Western Europe each year will
almost double until around 2018 (Peto et al.
1999). Second, removal of preexisting
asbestos is a current source of occupational
exposure. Third, a large portion of the
asbestos used in the past is still present in the
general environment and inevitably causes
release of ﬁbers into the air because of aging
and disintegration. The asbestos concentra-
tions that may currently be encountered in
the home environment are much lower than
those previously present in the occupational
setting; however, such microdoses should not
be disregarded because of the apparent lack of
a safety threshold for the risk of mesothe-
lioma. Low asbestos doses, insufficient to
cause asbestosis and lung cancer, may express
high pathogenetic potential for mesothelioma
(Selikoff 1978).
Thus, clinicians should be aware of the
possibility of mesothelioma, pleural or peri-
toneal, among patients with previous asbestos
exposure. In such cases, careful occupational
and environmental anamnesis may correctly
address diagnosis and, consequently, treat-
ment and prognosis. Discovery of a causal
link between asbestos exposure and disease
implies important medicolegal duties. The
case described here had to be reported to the
judicial authority (as established by the
Italian Penal Code) and was referred to the
Italian Workers’ Compensation Authority,
which recognized the occupational origin of
the disease.
After the correct diagnosis was formulated,
the patient was treated with cytoreductive
surgery associated with continuous hyperther-
mic peritoneal perfusion (CHHP) and sur-
vived 23 months. Until recently, peritoneal
mesothelioma was considered incurable, with
a median survival of less than 1 year from
diagnosis. Several different approaches had
been unsuccessfully attempted in the past,
including surgery, systemic chemotherapy,
whole abdominal irradiation, and intraperi-
toneal administration of radioisotopes (32P,
198Au) or antiproliferative drugs (thiotepa,
bleomycin) (Antman et al. 1983; Sridhar
et al. 1992). No dominant therapeutic guide-
line currently exists. During the last few years
(de Bree et al. 2000; Ma et al. 1997; Sebbag
et al. 2000; Sugarbaker et al. 2002), a new
integrated therapeutic strategy has been intro-
duced in which the diffused abdominal tumor
is removed by peritonectomy and resection of
the involved organs; the peritoneal cavity is
then successively inundated with a solution
containing antitumor drugs (cisplatin, doxo-
rubicin) heated to 41–42°C. During this
phase, the surgeon manually distributes the
liquid into the peritoneal cavity to allow the
drugs to reach all the surfaces. Early post-
operative intraperitoneal paclitaxel treatment
may also be associated (Sugarbaker et al.
2002). Regional treatments avoid systemic
toxicity and take advantage of the peritoneal–
plasma barrier and first-passage clearance of
cytostatic drugs by the liver. Tumor debulk-
ing before intraperitoneal chemotherapy is
essential for the effectiveness of treatment
because the penetration depth of the drugs is
limited to < 5 mm (Averbach and Sugarbaker
1996). This multimodality technique has
resulted in successful palliation of ascites and
in median survivals up to 50–60 months,
with projected 3-year survival rates up to 60%
(Sugarbaker et al. 2002). Survival has been
reported more than 5 years after treatment
(Sebbag et al. 2000; Sugarbaker et al. 2002).
This implies that, when diagnosed early, peri-
toneal mesothelioma is treatable with reason-
able expectations for high quality of life and
potential cure.
Conclusion
The patient reported here illustrates the diag-
nostic problems posed by peritoneal mesothe-
lioma. The epithelial subtype of this tumor
often assumes a papillary and/or glandular
cytoarchitecture, falsely suggesting the pres-
ence of metastatic adenocarcinoma at routine
histopathological examination. In such cases,
the doubts can be resolved using occupational
history and immunohistochemistry. The
restrictive laws recently introduced by several
countries have reduced but not eliminated the
risk of asbestos-induced mesothelioma.
Because of the long latency of this disease,
individuals exposed in the past, either in the
workplace or in the general environment,
require careful surveillance.
Correct diagnosis of peritoneal meso-
thelioma allows the adoption of innovative
therapeutic procedures (cytoreductive surgery
plus CHHP), which offers prolonged survival
and increased quality of life. When asbestos is
involved in the causation of the disease, accu-
rate diagnostic assessment is also important in
relation to medicolegal issues and occupation-
related compensation claims.
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